Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
A domain-specific, custom-trained large language model for the differential diagnosis and treatment planning of lymphedema, lipedema, and venous insufficiency.
The differential diagnosis of lower limb swelling remains problematic in clinical practice, as lymphedema, lipedema, and peripheral venous disease often present with similar features. Therefore, we developed LymphedemaGPT, a GPT-5-based clinical assistant designed to help practitioners navigate these diagnostic complexities.
LymphedemaGPT was designed to analyze structured patient data to extract clinical summaries, present possible diagnoses with percentage probabilities, create differential diagnosis tables, suggest additional diagnostic tests, and generate evidence-based treatment plans.
LymphedemaGPT's responses are based on seven scientific publications uploaded to the system, in addition to the Sleigh BC & Manna B (2023) and Rockson approaches. Owing to this resource integration, the model can provide more reliable and consistent recommendations aligned with evidence-based medicine principles based on current guidelines and scientific publications.
Extensive prompt engineering techniques were applied to optimize the diagnostic and therapeutic accuracy of LymphedemaGPT.
The model is programmed to prioritize the questioning phase until a diagnosis is confirmed. In the initial responses, only structured anamnesis questions were asked, and after sufficient information was collected, systematic analysis and treatment planning were initiated. The response flow was designed as follows: (1) history collection, (2) preliminary assessment, (3) additional questioning (if necessary), and (4) systematic analysis and treatment planning when sufficient data were obtained.
The following patient data was presented to LymphedemaGPT in a structured format:
Demographic data: Age, gender, height, weight Medical history: Additional illnesses, medications used, habits (smoking, alcohol) Complaint characteristics: Time of onset, affected area, symptoms (pain, heaviness, numbness, tingling, stiffness, limited movement, weakness, etc.) Physical examination findings: Stemmer sign, swelling change with elevation, skin findings Medical history: History of infection, history of surgery, history of malignancy (radiotherapy, chemotherapy, lymph node dissection, type of cancer) Imaging: Doppler ultrasonography and lymphoscintigraphy results, if available
LymphedemaGPT was asked to respond in the following 12-part standard format: (1) Clinical Summary, (2) Possible Diagnoses (% probability), (3) Differential Diagnosis, (4) Recommended Diagnostic Tests, (5) Treatment Plan, (6) Patient Education and Follow-up, (7) Red Flags, (8) references, (9) Level of Evidence and Confidence Score, (10) Ethical Note, (11) Data Summary (JSON/CSV), and (12) Analysis Timestamp.
The performance of LymphedemaGPT was evaluated by experienced physicians based on the following eight criteria:
Each criterion was scored using a 5-point Likert scale: 5 = excellent/completely suitable, 4 = good/significantly suitable, 3 = moderate/partially suitable, 2 = poor/inadequate, and 1 = very poor/not suitable. The maximum score for each case was 40 (8 criteria × 5 points), and the minimum score was 8.
Two experienced physicians independently performed the evaluation. The evaluators were physical medicine and rehabilitation specialists experienced in the management of lymphedema and lipedema, and they independently performed the scoring.
Not provided
Not provided
Not provided
Not provided
Not provided
| Name | Type | Description | Arm Group Labels | Other Names |
|---|---|---|---|---|
| a domain-specific, custom-trained large language model for the differential diagnosis and treatment planning of lymphedema, lipedema, and venous insufficiency | Other | LymphedemaGPT was designed to analyze structured patient data to extract clinical summaries, present possible diagnoses with percentage probabilities, create differential diagnosis tables, suggest additional diagnostic tests, and generate evidence-based treatment plans. |
| Measure | Description | Time Frame |
|---|---|---|
| Diagnostic accuracy rate | Percentage of cases where the primary diagnosis (most likely diagnosis) was correctly determined. The maximum percentage for each case was 100, and the minimum percentage was 0. Higher percentages mean a better outcome. | 1 hour |
| Treatment adequacy rate | Percentage of treatment recommendations consistent with current guidelines. The maximum percentage for each case was 100, and the minimum percentage was 0. Higher percentages mean a better outcome. | 1 hour |
| Average criterion score | Average Likert score of two evaluators for each criterion. The maximum score for each case was 40, and the minimum score was 8. higher scores mean a better outcome. | 1 hour |
| Measure | Description | Time Frame |
|---|---|---|
| Overall performance score | Overall average of all criteria and cases. The maximum score for each case was 40, and the minimum score was 8. higher scores mean a better outcome. | 1 hour |
Not provided
Inclusion Criteria:
Exclusion Criteria:
Not provided
Not provided
Not provided
secondary lymphedema cases (post-pelvic surgery, post-breast cancer), primary lymphedema cases, lipedema cases (different types and stages), chronic venous insufficiency cases, mixed edema cases, and atypical presentations with diagnostic difficulties
| Name | Role | Phone | Extension | |
|---|---|---|---|---|
| Yunus Emre Doğan, MD | Contact | +90 506 051 25 00 | ynsemredgn91@gmail.com |
| Name | Affiliation | Role |
|---|---|---|
| Yunus Emre Doğan, MD | Istanbul Fatih Sultan Mehmet Training and Research Hospital | Principal Investigator |
| Feyza Akan Begoğlu, MD | Istanbul Fatih Sultan Mehmet Training and Research Hospital | Study Chair |
| Facility | Status | City | State | ZIP | Country | Contacts |
|---|---|---|---|---|---|---|
| Istanbul Fatih Sultan Mehmet Training and Research Hospital | Istanbul | Istanbul | 34704 | Turkey (Türkiye) |
| PubMed Identifier | Type | Citation | Retractions |
|---|---|---|---|
| 38792666 | Background | Leypold T, Lingens LF, Beier JP, Boos AM. Integrating AI in Lipedema Management: Assessing the Efficacy of GPT-4 as a Consultation Assistant. Life (Basel). 2024 May 20;14(5):646. doi: 10.3390/life14050646. | |
| 35813896 | Background | Eldaly AS, Avila FR, Torres-Guzman RA, Maita K, Garcia JP, Serrano LP, Forte AJ. Artificial intelligence and lymphedema: State of the art. J Clin Transl Res. 2022 Jun 1;8(3):234-242. eCollection 2022 Jun 29. |
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
| ID | Term |
|---|---|
| D008209 | Lymphedema |
| ID | Term |
|---|---|
| D008206 | Lymphatic Diseases |
| D006425 | Hemic and Lymphatic Diseases |
Not provided
Not provided
Not provided
Not provided
Not provided
| Mesut Canlı, MD | Istanbul Fatih Sultan Mehmet Training and Research Hospital | Study Chair |
| İlknur Aktaş, MD, Prof. | Istanbul Fatih Sultan Mehmet Training and Research Hospital | Study Chair |
| Feyza Ünlü Özkan, MD, Prof. | Istanbul Fatih Sultan Mehmet Training and Research Hospital | Study Chair |
| 37830256 | Background | Wojcik S, Rulkiewicz A, Pruszczyk P, Lisik W, Pobozy M, Domienik-Karlowicz J. Beyond ChatGPT: What does GPT-4 add to healthcare? The dawn of a new era. Cardiol J. 2023;30(6):1018-1025. doi: 10.5603/cj.97515. Epub 2023 Oct 13. |
| 37917126 | Background | Mesko B. The Impact of Multimodal Large Language Models on Health Care's Future. J Med Internet Res. 2023 Nov 2;25:e52865. doi: 10.2196/52865. |